People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bioreclamation Holdings, LLC | — | Biotechnology | Series B | $25.4M | $1.0B | 2013 |
Jeffrey Gatz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey Gatz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William L. Willhite | 1 | 6 |
| Stephen J. Sullivan | 1 | 4 |
| Robert C. Dunn | 1 | 2 |
| Clifford Raynor | 1 | 1 |
| Scott Alson | 1 | 1 |
| Harry Holiday III | 1 | 1 |
| William Tempone | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.